Picture Berlin Partner Voices Robinson Data for Precision Medicine 650x100px

Product › Details

Glucophage®

	Next higher product group	metformin (INN v)
	Status	1994-01-01 sales existent
	Status	1998-01-01 sales existent
	Organisation	Merck (DE) (Group)
	Organisation 2	Lipha (Group)
	Group	Merck (DE) (Group)

Record changed: 2023-07-10

Picture Swiss Biotech Association Swiss Biotech Days 2024 SBD24 Basel 650x200px

More documents for antidiabetic_o

[1] Evolva Holding S.A.. (11/14/23). "Press Release: Evolva and Breko Broaden Partnership by Signing Agreement for the Exclusive Distribution of Veri-te Resveratrol in Germany, Austria, Thailand and Vietnam". Reinach....
[2] Sanofi S.A.. (3/13/23). "Press Release: Sanofi to Acquire Provention Bio, Adding to Portfolio TZIELD, the First Disease-modifying Treatment for the Delay of Stage 3 Type 1 Diabetes (T1D)". Paris & Red Bank, NJ....
[3] Pancryos ApS. (5/24/22). "Press Release: Pancryos Announces Exclusive Global License Agreement for First in Class Macroencapsulation Device". Copenhagen....
[4] Zealand Pharma A/S. (3/30/22). "Press Release: Zealand Pharma Appoints New Chief Executive Officer, Refocuses Strategy to Prioritize Research & Development and Streamlines Operations". Copenhagen & Boston, MA....
[5] Enthera S.r.l.. (7/7/21). "Press Release: Enthera Pharmaceuticals Opens Early Drug Discovery Unit at OpenZone Life Sciences Campus to Expand Autoimmune Disease Research". Milan....
[6] Enthera S.r.l.. (1/28/21). "Press Release: Enthera Pharmaceuticals Extends Series A Financing, Raising a Total of €35 million". Milan....
[7] Enthera S.r.l.. (12/3/20). "Press Release: Enthera Pharmaceuticals Appoints Kazumi Shiosaki to Its Board of Directors and Lisa Olson to Its Scientific Advisory Board to Push Forward Company Growth and Development". Milan....
[8] Imcyse S.A.. (9/7/20). "Press Release: Imcyse Announces the Appointment of Denis Bedoret as Chief Executive Officer". Liège....
[9] Enthera S.r.l.. (7/28/20). "Press Release: Enthera Pharmaceuticals Raises €28 Million in Series A Financing to Advance Restorative Therapy for Type 1 Diabetes and Inflammatory Bowel Disease". Milan....
[10] Poxel S.A.. (5/25/20). "Press Release: Poxel Announces Program Update and Preclinical Results on PXL770 for NASH Combinations and Other Metabolic Diseases". Lyon....

To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«

Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]